Faster global financial news!
Weight-Loss Pills
-
Novo Nordisk, the Danish pharmaceutical giant, saw its shares fall by 7% despite setting a $23 billion sales target for its weight-loss drug.
Novo Nordisk's share price fell by as much as 7% on Monday after the company unveiled new growth ambitions aimed at reinvigorating its position in the booming obesity drug market. The company plans to
-
Eli Lilly's Q2 revenue grew by 48%, and it plans to submit a BLA for its weight-loss drug Retatrutide in Q1 2027; Novo Nordisk, on the other hand, laid off 12,000 employees.
Eli Lilly reported a 48% increase in Q2 2026 revenue and raised its full-year guidance. Its weight-loss drugs, Mounjaro and Zepbound, generated a combined $14.9 billion in sales in Q2, capturing appro
-
Eli Lilly (LLY) stock rose 3.37% to $1223.04, narrowing the early lead of Novo Nordisk in the weight-loss drug market.
Eli Lilly's stock price has rebounded from its 50-day moving average and is currently above its 21-day and 10-day moving averages, demonstrating strong market performance. The company is challenging N
-
Novo Nordisk, the Danish pharmaceutical giant, saw its shares fall by 7% despite setting a $23 billion sales target for its weight-loss drug.
Novo Nordisk's share price fell by as much as 7% on Monday after the company unveiled new growth ambitions aimed at reinvigorating its position in the booming obesity drug market. The company plans to
-
Eli Lilly's Q2 revenue grew by 48%, and it plans to submit a BLA for its weight-loss drug Retatrutide in Q1 2027; Novo Nordisk, on the other hand, laid off 12,000 employees.
Eli Lilly reported a 48% increase in Q2 2026 revenue and raised its full-year guidance. Its weight-loss drugs, Mounjaro and Zepbound, generated a combined $14.9 billion in sales in Q2, capturing appro
-
Eli Lilly (LLY) stock rose 3.37% to $1223.04, narrowing the early lead of Novo Nordisk in the weight-loss drug market.
Eli Lilly's stock price has rebounded from its 50-day moving average and is currently above its 21-day and 10-day moving averages, demonstrating strong market performance. The company is challenging N
- No data
Weight-Loss Pills
24H Trending
-
1
Oasys (OAS) Project Analysis: The Intersection of Gaming Chains and On-Chain Perpetual Contracts
-
2
RSS3: Web3 Decentralized Information Protocol and Its Token Analysis
-
3
Crypto market enters October after strong Q3, eyes Ethereum testnet and ETF flows
-
4
HAN Token Analysis: What is HanChain? How to Trade and Acquire It?
-
5
ENJ Trading Guide: How to Buy and Sell Enjin Tokens and Their Listed Exchanges
-
6
An Analysis of USDC's Performance and Role During Financial Crises
-
7
BAI Token Analysis: An Overview of a Crypto Asset with Multiple Identities
-
8
YFC (Yearnchange) Token Analysis: The Current State and Risks of DeFi Copycats
-
9
OKX Exchange Reliability Analysis and Latest Developments
-
10
ILV Token and Chainlink: Deep Integration and Innovative Potential in the Illuvium Blockchain Game
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
